ORCID as entered in ROS

Select Publications
2025, 'Response to “Do We Need On-Site Drug Analysis Within Supervised Injecting Facilities?”', Drug and Alcohol Review, 44, pp. 1296 - 1297, http://dx.doi.org/10.1111/dar.14067
,2025, 'Supervised Injecting Room Cohort Study (SIRX): study protocol', BMJ Open, 15, pp. e091337, http://dx.doi.org/10.1136/bmjopen-2024-091337
,2025, 'Treatment completion among Australians attending publicly-funded specialist alcohol and other drug treatment services', Journal of Substance Use and Addiction Treatment, 169, http://dx.doi.org/10.1016/j.josat.2024.209588
,2025, 'A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14079
,2025, 'Analyses Updated to 2022–23 on Australian Attitudes Towards Supervised Injecting Facilities', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14089
,2025, 'Identification of nitazene-related deaths in Australia: How do we make it accurate and timely?', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.14028
,2024, 'Characteristics of attrition within the SuperMIX cohort of people who inject drugs: a multiple event discrete-time survival analysis', BMC Medical Research Methodology, 24, http://dx.doi.org/10.1186/s12874-024-02377-1
,2024, 'Changes in Australians' attitudes towards supervised injecting facilities', Drug and Alcohol Review, 43, pp. 1892 - 1904, http://dx.doi.org/10.1111/dar.13937
,2024, '20-year trends in Australian methamphetamine-related deaths, 2001–2020', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104548
,2024, 'Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney', Drug and Alcohol Review, 43, pp. 1597 - 1606, http://dx.doi.org/10.1111/dar.13900
,2024, 'The role of on-site drug analysis within supervised injecting facilities: A case presentation of an adverse event highlighting need', Drug and Alcohol Review, 43, pp. 1592 - 1596, http://dx.doi.org/10.1111/dar.13909
,2023, 'Outrage and algorithms: Shifting drug-related stigma in a digital world', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104224
,2023, 'The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia', Public Health, 224, pp. 90 - 97, http://dx.doi.org/10.1016/j.puhe.2023.08.019
,2022, 'Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001–2021', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103854
,2022, 'Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions', Medical Journal of Australia, 217, pp. 385 - 387, http://dx.doi.org/10.5694/mja2.51716
,2022, 'Commentary on Skulberg et al.: Naloxone administration—finding the balance', Addiction, 117, pp. 1668 - 1669, http://dx.doi.org/10.1111/add.15887
,2022, 'The onset and severity of acute opioid toxicity in heroin overdose cases: a retrospective cohort study at a supervised injecting facility in Melbourne, Australia', Clinical Toxicology, 60, pp. 1227 - 1234, http://dx.doi.org/10.1080/15563650.2022.2126371
,2021, 'Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia', Harm Reduction Journal, 18, http://dx.doi.org/10.1186/s12954-021-00471-x
,2021, 'Trends in MDMA-related mortality across four countries', Addiction, 116, pp. 3094 - 3103, http://dx.doi.org/10.1111/add.15493
,2021, 'New Australian guidelines for the treatment of alcohol problems: an overview of recommendations', Medical Journal of Australia, 215, pp. S3 - S32, http://dx.doi.org/10.5694/mja2.51254
,2021, 'Providing appropriate treatment and care to people with alcohol problems: a summary for key specific populations', MEDICAL JOURNAL OF AUSTRALIA, 215, pp. S21 - S27
,2021, 'Assessing drug consumption rooms and longer term (5 year) impacts on community and clients', Risk Management and Healthcare Policy, 14, pp. 4639 - 4647, http://dx.doi.org/10.2147/RMHP.S244720
,2020, 'MDMA-related deaths in Australia 2000 to 2018', International Journal of Drug Policy, 76, http://dx.doi.org/10.1016/j.drugpo.2019.102630
,2019, 'Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids', Drug and Alcohol Dependence, 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.035
,2019, 'The prevalence and factors associated with smoking among lesbian and bisexual women: Analysis of the Australian National Drug Strategy Household Survey', International Journal of Drug Policy, 70, pp. 54 - 60, http://dx.doi.org/10.1016/j.drugpo.2019.03.028
,2018, 'Typology of new psychoactive substance use among the general Australian population', Drug and Alcohol Dependence, 188, pp. 126 - 134, http://dx.doi.org/10.1016/j.drugalcdep.2018.03.034
,2018, 'Accurate identification of opioid overdose deaths using coronial data', Forensic Science International, 287, pp. 40 - 46, http://dx.doi.org/10.1016/j.forsciint.2018.03.032
,2018, 'A nationwide study of the extent and factors associated with fentanyl use in Australia', Research in Social and Administrative Pharmacy, 14, pp. 303 - 308, http://dx.doi.org/10.1016/j.sapharm.2017.04.002
,2017, 'Trends in heroin and pharmaceutical opioid overdose deaths in Australia', Drug and Alcohol Dependence, 179, pp. 291 - 298, http://dx.doi.org/10.1016/j.drugalcdep.2017.07.018
,2017, 'Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre', Drug and Alcohol Dependence, 176, pp. 126 - 132, http://dx.doi.org/10.1016/j.drugalcdep.2017.02.027
,2017, 'The recovery of online drug markets following law enforcement and other disruptions', Drug and Alcohol Dependence, 173, pp. 159 - 162, http://dx.doi.org/10.1016/j.drugalcdep.2017.01.004
,2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426
,2017, 'Corrigendum to “Characterising dark net marketplace purchasers in a sample of regular psychostimulant users” [International Journal of Drug Policy 35 (2016) 32–37]((S0955395916000335)(10.1016/j.drugpo.2016.01.010))', International Journal of Drug Policy, 39, pp. 140, http://dx.doi.org/10.1016/j.drugpo.2016.11.001
,2017, 'Accidental drug-induced deaths due to opioids in Australia, 2013', NIDIP, http://www.drugtrends.org.au/reports/nidip-opioid-deaths-2013/
,2017, 'Cocaine and methamphetamine related drug-induced deaths in Australia, 2013', NIDIP Bulletin, pp. 1 - 5
,2017, 'Drug-related hospital stays in Australia, 1993-2015', NIDIP Bulletin, pp. 1 - 16
,2017, 'Drugs and the Internet', Drugs and New Technologies (DNet) Bulletin, pp. 1 - 12, https://dlnstorage.blob.core.windows.net/drt101/1893/dnet-8th-buletin_website.pdf
,2017, 'Drugs and the Internet', Drugs and New Technologies (DNet) Bulletin, pp. 1 - 11, https://dlnstorage.blob.core.windows.net/drt101/1915/dnet-9th-bulletin_final.pdf
,2017, 'Use and knowledge of darknet markets among people who regularly use stimulants', EDRS Drug Trends Bulletin, pp. 1 - 4, https://ndarc.med.unsw.edu.au/resource/edrs-drug-trends-bulletin-december-2017-use-and-knowledge-darknet-markets-among-people-who
,2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018
,2016, 'Characterising dark net marketplace purchasers in a sample of regular psychostimulant users', International Journal of Drug Policy, 35, pp. 32 - 37, http://dx.doi.org/10.1016/j.drugpo.2016.01.010
,2016, 'Who sells what? Country specific differences in substance availability on the Agora cryptomarket', International Journal of Drug Policy, 35, pp. 16 - 23, http://dx.doi.org/10.1016/j.drugpo.2016.07.004
,2016, 'New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015', Drug and Alcohol Dependence, 161, pp. 110 - 118, http://dx.doi.org/10.1016/j.drugalcdep.2016.01.024
,2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014', MEDICAL JOURNAL OF AUSTRALIA, 204, http://dx.doi.org/10.5694/mja15.00671
,2016, 'Sexual identity and prevalence of alcohol and other drug use among Australians in the general population', International Journal of Drug Policy, 28, pp. 76 - 82, http://dx.doi.org/10.1016/j.drugpo.2015.11.005
,2016, 'Accidental drug-induced deaths due to opioids in Australia, 2012', NIDIP Bulletin, pp. 1 - 9, https://dlnstorage.blob.core.windows.net/drt101/1744/ndarc-bulletin-opioid-deaths-2012.pdf
,2016, 'Drugs and the Internet', Drugs and New Technologies (DNeT) Bulletin, Issue 7, October, pp. 1 - 14, http://www.drugtrends.org.au/reports/dnetbulletin_issue7_finalpdf/
,2016, 'Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014', Medical Journal of Australia, 204, pp. 1.e1 - 1.e6, http://dx.doi.org/10.5694/mja15.00671
,2015, 'A response to Dolliver's "Evaluating drug trafficking on the Tor Network: Silk Road 2, the sequel"', INTERNATIONAL JOURNAL OF DRUG POLICY, 26, pp. 1124 - 1125, http://dx.doi.org/10.1016/j.drugpo.2015.05.017
,2015, 'A response to Dolliver's "Evaluating drug trafficking on the Tor network"', International Journal of Drug Policy, 26, pp. 1126 - 1127, http://dx.doi.org/10.1016/j.drugpo.2015.07.001
,